<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35876881</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.</ArticleTitle><Pagination><StartPage>437</StartPage><EndPage>464</EndPage><MedlinePgn>437-464</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-022-02470-z</ELocationID><Abstract><AbstractText>Dysfunction and degeneration of synapses is a common feature of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). A GGGGCC hexanucleotide repeat expansion in the C9ORF72 gene is the main genetic cause of ALS/FTD (C9ALS/FTD). The repeat expansion leads to reduced expression of the C9orf72 protein. How C9orf72 haploinsufficiency contributes to disease has not been resolved. Here we identify the synapsin family of synaptic vesicle proteins, the most abundant group of synaptic phosphoproteins, as novel interactors of C9orf72 at synapses and show that C9orf72 plays a cell-autonomous role in the regulation of excitatory synapses. We mapped the interaction of C9orf72 and synapsin to the N-terminal longin domain of C9orf72 and the conserved C domain of synapsin, and show interaction of the&#xa0;endogenous proteins in synapses. Functionally, C9orf72 deficiency reduced the number of excitatory synapses and decreased synapsin levels at remaining synapses in vitro in hippocampal neuron cultures and in vivo in the hippocampal mossy fibre system of C9orf72 knockout mice. Consistent with synaptic dysfunction, electrophysiological recordings identified impaired excitatory neurotransmission and network function in hippocampal neuron cultures with reduced C9orf72 expression, which correlated with a severe depletion of synaptic vesicles from excitatory synapses in the hippocampus of C9orf72 knockout mice. Finally, neuropathological analysis of post-mortem sections of C9ALS/FTD patient hippocampus with C9orf72 haploinsufficiency revealed a marked reduction in synapsin, indicating that disruption of the interaction between C9orf72 and synapsin may contribute to ALS/FTD pathobiology. Thus, our data show that C9orf72 plays a cell-autonomous role in the regulation of neurotransmission at excitatory synapses by interaction with synapsin and modulation of synaptic vesicle pools, and identify a novel role for C9orf72 haploinsufficiency in synaptic dysfunction in C9ALS/FTD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bauer</LastName><ForeName>Claudia S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cohen</LastName><ForeName>Rebecca N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sironi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5287-3784</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livesey</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-3441-7977</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillingwater</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0002-0306-5577</Identifier><AffiliationInfo><Affiliation>Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Hugh Robson Building, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for Motor Neuron Disease Research, Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Highley</LastName><ForeName>J Robin</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fillingham</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coldicott</LastName><ForeName>Ian</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-1919-7419</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Emma F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Yolanda B</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0003-4197-2036</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grierson</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-7039-6731</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1055-1271</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vos</LastName><ForeName>Kurt J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0003-2161-6309</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. k.de_vos@sheffield.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. k.de_vos@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DEVOS/OCT13/870-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M013251/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S025979/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000631234">SYN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016704">Synapsins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016704" MajorTopicYN="N">Synapsins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Synapse</Keyword><Keyword MajorTopicYN="N">Synapsin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35876881</ArticleId><ArticleId IdType="pmc">PMC9381633</ArticleId><ArticleId IdType="doi">10.1007/s00401-022-02470-z</ArticleId><ArticleId IdType="pii">10.1007/s00401-022-02470-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Roczniak-Ferguson A, Ferguson SM. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol Biol Cell. 2016;27:3040&#x2013;3051. doi: 10.1091/mbc.E16-01-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-01-0003</ArticleId><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGL, et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin I, Rosenmund C, S&#xfc;dhof TC, Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature. 1999;400:457&#x2013;461. doi: 10.1038/22768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/22768</ArticleId><ArticleId IdType="pubmed">10440375</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardy C, van den Hurk M, Eames T, Marchand C, Hernandez RV, Kellogg M, et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc Natl Acad Sci USA. 2015;112:E2725&#x2013;E2734. doi: 10.1073/pnas.1504393112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1504393112</ArticleId><ArticleId IdType="pmc">PMC4443325</ArticleId><ArticleId IdType="pubmed">25870293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, et al. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology. 2013;33:122&#x2013;133. doi: 10.1111/j.1440-1789.2012.01332.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2012.01332.x</ArticleId><ArticleId IdType="pmc">PMC3449045</ArticleId><ArticleId IdType="pubmed">22702520</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, Ruffenach F, Negroni L, Sellier C, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39:e100574. doi: 10.15252/embj.2018100574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A-L, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603:131&#x2013;137. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Pan YE, Giacomotto J, Patten SA. Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish. Commun Biol. 2021;4:792. doi: 10.1038/s42003-021-02302-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02302-y</ArticleId><ArticleId IdType="pmc">PMC8233344</ArticleId><ArticleId IdType="pubmed">34172817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesca F, Baldelli P, Valtorta F, Benfenati F. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol. 2010;91:313&#x2013;348. doi: 10.1016/j.pneurobio.2010.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.04.006</ArticleId><ArticleId IdType="pubmed">20438797</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman WL, Bykhovskaia M. Cooperative regulation of neurotransmitter release by Rab3a and synapsin II. Mol Cell Neurosci. 2010;44:190&#x2013;200. doi: 10.1016/j.mcn.2010.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2010.03.007</ArticleId><ArticleId IdType="pmc">PMC4522281</ArticleId><ArticleId IdType="pubmed">20338242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrionero A, Horvitz HR. A C9orf72 ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr Biol. 2018;28:1522&#x2013;1535.e5. doi: 10.1016/j.cub.2018.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.03.063</ArticleId><ArticleId IdType="pubmed">29731301</ArticleId></ArticleIdList></Reference><Reference><Citation>Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci. 2006;26:1303&#x2013;1313. doi: 10.1523/JNEUROSCI.2699-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2699-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674579</ArticleId><ArticleId IdType="pubmed">16436618</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, Van Deerlin VM, van Swieten JC, Al-Chalabi A, Ludolph AC, Weishaupt JH, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol. 2014;76:120&#x2013;133. doi: 10.1002/ana.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24198</ArticleId><ArticleId IdType="pmc">PMC4137231</ArticleId><ArticleId IdType="pubmed">24931836</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelstein AD, Tsuchida MA, Amodaj N, Pinkard H, Vale RD, Stuurman N. Advanced methods of microscope control using &#x3bc;Manager software. J Biol Methods. 2014;1:e10. doi: 10.14440/jbm.2014.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.14440/jbm.2014.36</ArticleId><ArticleId IdType="pmc">PMC4297649</ArticleId><ArticleId IdType="pubmed">25606571</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RA, Levina V, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui-Bories J, Martinat C, et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerth F, J&#xe4;pel M, Pechstein A, Kochlamazashvili G, Lehmann M, Puchkov D, et al. Intersectin associates with synapsin and regulates its nanoscale localization and function. Proc Natl Acad Sci USA. 2017;114:12057&#x2013;12062. doi: 10.1073/pnas.1715341114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1715341114</ArticleId><ArticleId IdType="pmc">PMC5692602</ArticleId><ArticleId IdType="pubmed">29078407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghatak S, Talantova M, McKercher SR, Lipton SA. Novel therapeutic approach for excitatory/inhibitory imbalance in neurodevelopmental and neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2021;61:701&#x2013;721. doi: 10.1146/annurev-pharmtox-032320-015420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-032320-015420</ArticleId><ArticleId IdType="pubmed">32997602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillingwater TH, Ingham CA, Coleman MP, Ribchester RR. Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene. J Anat. 2003;203:265&#x2013;276. doi: 10.1046/j.1469-7580.2003.00214.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-7580.2003.00214.x</ArticleId><ArticleId IdType="pmc">PMC1571169</ArticleId><ArticleId IdType="pubmed">14529044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillingwater TH, Ingham CA, Parry KE, Wright AK, Haley JE, Wishart TM, et al. Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. Brain. 2006;129:1546&#x2013;1556. doi: 10.1093/brain/awl101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl101</ArticleId><ArticleId IdType="pubmed">16738060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioved&#xec; S, Darchen F, Valtorta F, Greengard P, Benfenati F. Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction. J Biol Chem. 2004;279:43769&#x2013;43779. doi: 10.1074/jbc.M404168200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M404168200</ArticleId><ArticleId IdType="pubmed">15265868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioved&#xec; S, Vaccaro P, Valtorta F, Darchen F, Greengard P, Cesareni G, et al. Synapsin is a novel Rab3 effector protein on small synaptic vesicles. I. Identification and characterization of the synapsin I-Rab3 interactions in vitro and in intact nerve terminals. J Biol Chem. 2004;279:43760&#x2013;43768. doi: 10.1074/jbc.M403293200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403293200</ArticleId><ArticleId IdType="pubmed">15265865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler D, Takagishi Y, Feng J, Ren Y, Rodriguiz RM, Wetsel WC, et al. Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci. 2004;24:11368&#x2013;11380. doi: 10.1523/JNEUROSCI.3795-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3795-04.2004</ArticleId><ArticleId IdType="pmc">PMC6730366</ArticleId><ArticleId IdType="pubmed">15601943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray EG, Whittaker VP. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 1962;96:79&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1244174</ArticleId><ArticleId IdType="pubmed">13901297</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge CM, Pickett E, Spires-Jones TL. Synaptic pathology: a shared mechanism in neurological disease. Ageing Res Rev. 2016;28:72&#x2013;84. doi: 10.1016/j.arr.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.04.005</ArticleId><ArticleId IdType="pubmed">27108053</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, et al. Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:213&#x2013;226. doi: 10.1007/s00401-017-1797-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1797-4</ArticleId><ArticleId IdType="pmc">PMC5773656</ArticleId><ArticleId IdType="pubmed">29273900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilfiker S, Benfenati F, Doussau F, Nairn AC, Czernik AJ, Augustine GJ, et al. Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci. 2005;25:2658&#x2013;2669. doi: 10.1523/JNEUROSCI.4278-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4278-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725186</ArticleId><ArticleId IdType="pubmed">15758176</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P. Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci. 1999;354:269&#x2013;279. doi: 10.1098/rstb.1999.0378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.1999.0378</ArticleId><ArticleId IdType="pmc">PMC1692497</ArticleId><ArticleId IdType="pubmed">10212475</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WY, Tai YK, Chang JC, Liang J, Tyan SH, Chen S, et al. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy. 2019;15:827&#x2013;842. doi: 10.1080/15548627.2019.1569441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569441</ArticleId><ArticleId IdType="pmc">PMC6526867</ArticleId><ArticleId IdType="pubmed">30669939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135:709&#x2013;722. doi: 10.1093/brain/awr354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr354</ArticleId><ArticleId IdType="pmc">PMC3286328</ArticleId><ArticleId IdType="pubmed">22344582</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen BK, Schuldi MH, McAvoy K, Russell KA, Boehringer A, Curran BM, et al. Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment. EMBO Mol Med. 2020;12:e10722. doi: 10.15252/emmm.201910722.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910722</ArticleId><ArticleId IdType="pmc">PMC7207170</ArticleId><ArticleId IdType="pubmed">32347002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato AS, Zhou W, Milstein AD, Knierman MD, Siuda ER, Dotzlaf JE, et al. New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci. 2007;27:4969&#x2013;4977. doi: 10.1523/JNEUROSCI.5561-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5561-06.2007</ArticleId><ArticleId IdType="pmc">PMC6672084</ArticleId><ArticleId IdType="pubmed">17475805</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S, Molchanova SM, Wright AK, Edwards A, Cooper JD, Taira T, et al. Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis. J Neuropathol Exp Neurol. 2011;70:1089&#x2013;1096. doi: 10.1097/NEN.0b013e318238fc28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318238fc28</ArticleId><ArticleId IdType="pmc">PMC3242052</ArticleId><ArticleId IdType="pubmed">22082660</ArticleId></ArticleIdList></Reference><Reference><Citation>Koegl M, Uetz P. Improving yeast two-hybrid screening systems. Brief Funct Genom Proteomic. 2007;6:302&#x2013;312. doi: 10.1093/bfgp/elm035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/elm035</ArticleId><ArticleId IdType="pubmed">18218650</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CA, Vieira de S&#xe1; R, et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger-Burg D, Papadopoulos T, Brose N. Organizers of inhibitory synapses come of age. Curr Opin Neurobiol. 2017;45:66&#x2013;77. doi: 10.1016/j.conb.2017.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.04.003</ArticleId><ArticleId IdType="pubmed">28460365</ArticleId></ArticleIdList></Reference><Reference><Citation>Laflamme C, McKeever PM, Kumar R, Schwartz J, Kolahdouzan M, Chen CX, et al. Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. Elife. 2019;8:e48363. doi: 10.7554/eLife.48363.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.48363</ArticleId><ArticleId IdType="pmc">PMC6794092</ArticleId><ArticleId IdType="pubmed">31612854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Lorenzini I, Mota TA, Bell S, Mahan TE, Ulrich JD, et al. C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron. 2021;109:2275&#x2013;2291.e8. doi: 10.1016/j.neuron.2021.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8298293</ArticleId><ArticleId IdType="pubmed">34133945</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenders AG, Lopes da Silva FH, Ghijsen WE, Verhage M. Rab3a is involved in transport of synaptic vesicles to the active zone in mouse brain nerve terminals. Mol Biol Cell. 2001;12:3095&#x2013;3102. doi: 10.1091/mbc.12.10.3095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.12.10.3095</ArticleId><ArticleId IdType="pmc">PMC60158</ArticleId><ArticleId IdType="pubmed">11598194</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine TP, Daniels RD, Gatta AT, Wong LH, Hayes MJ. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29:499&#x2013;503. doi: 10.1093/bioinformatics/bts725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts725</ArticleId><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman OJ, Sulzer D. The synaptic autophagy cycle. J Mol Biol. 2020;432:2589&#x2013;2604. doi: 10.1016/j.jmb.2019.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.12.028</ArticleId><ArticleId IdType="pmc">PMC7814399</ArticleId><ArticleId IdType="pubmed">31866297</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Livesey MR, Bilican B, Qiu J, Rzechorzek NM, Haghi G, Burr K, et al. Maturation of AMPAR composition and the GABAAR reversal potential in hPSC-derived cortical neurons. J Neurosci. 2014;34:4070&#x2013;4075. doi: 10.1523/JNEUROSCI.5410-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5410-13.2014</ArticleId><ArticleId IdType="pmc">PMC3951701</ArticleId><ArticleId IdType="pubmed">24623784</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhena F, Faustini G, Brembati V, Pizzi M, Benfenati F, Bellucci A. An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders. Neurosci Biobehav Rev. 2021;130:33&#x2013;60. doi: 10.1016/j.neubiorev.2021.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.08.011</ArticleId><ArticleId IdType="pubmed">34407457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene UNC13A. Nature. 2022;603:124&#x2013;130. doi: 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 2013;126:859&#x2013;879. doi: 10.1007/s00401-013-1181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuin C, Goodman A, Chernyshev V, Kamentsky L, Cimini BA, Karhohs KW, et al. Cell Profiler 3.0: next-generation image processing for biology. PLoS Biol. 2018;16:e2005970. doi: 10.1371/journal.pbio.2005970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2005970</ArticleId><ArticleId IdType="pmc">PMC6029841</ArticleId><ArticleId IdType="pubmed">29969450</ArticleId></ArticleIdList></Reference><Reference><Citation>Melloni RH, Hemmendinger LM, Hamos JE, DeGennaro LJ. Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus. J Comp Neurol. 1993;327:507&#x2013;520. doi: 10.1002/cne.903270404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.903270404</ArticleId><ArticleId IdType="pubmed">8440778</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray ME, Bieniek KF, Banks Greenberg M, DeJesus-Hernandez M, Rutherford NJ, van Blitterswijk M, et al. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathol. 2013;126:545&#x2013;554. doi: 10.1007/s00401-013-1161-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1161-2</ArticleId><ArticleId IdType="pmc">PMC3926101</ArticleId><ArticleId IdType="pubmed">23922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 2011;122:673&#x2013;690. doi: 10.1007/s00401-011-0907-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0907-y</ArticleId><ArticleId IdType="pmc">PMC3277860</ArticleId><ArticleId IdType="pubmed">22083254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasniceanu IS, Atwal MS, Souza CDS, Ferraiuolo L, Livesey MR. Emerging mechanisms underpinning neurophysiological impairments in C9ORF72 repeat expansion-mediated amyotrophic lateral sclerosis/frontotemporal dementia. Front Cell Neurosci. 2021;15:784833. doi: 10.3389/fncel.2021.784833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.784833</ArticleId><ArticleId IdType="pmc">PMC8715728</ArticleId><ArticleId IdType="pubmed">34975412</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins EM, Burr K, Banerjee P, Mehta AR, Dando O, Selvaraj BT, et al. Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction. Mol Neurodegener. 2021;16:13. doi: 10.1186/s13024-021-00433-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00433-8</ArticleId><ArticleId IdType="pmc">PMC7931347</ArticleId><ArticleId IdType="pubmed">33663561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ, Greengard P. Distinct pools of synaptic vesicles in neurotransmitter release. Nature. 1995;375:493&#x2013;497. doi: 10.1038/375493a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375493a0</ArticleId><ArticleId IdType="pubmed">7777058</ArticleId></ArticleIdList></Reference><Reference><Citation>Placek K, Baer GM, Elman L, McCluskey L, Hennessy L, Ferraro PM, et al. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2019;73:190&#x2013;199. doi: 10.1016/j.neurobiolaging.2018.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.031</ArticleId><ArticleId IdType="pmc">PMC6251755</ArticleId><ArticleId IdType="pubmed">30368160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletnikova O, Sloane KL, Renton AE, Traynor BJ, Crain BJ, Reid T, et al. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging. 2014;35:2419.e17&#x2013;21. doi: 10.1016/j.neurobiolaging.2014.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.009</ArticleId><ArticleId IdType="pmc">PMC4087047</ArticleId><ArticleId IdType="pubmed">24819148</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosahl TW, Spillane D, Missler M, Herz J, Selig DK, Wolff JR, et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature. 1995;375:488&#x2013;493. doi: 10.1038/375488a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375488a0</ArticleId><ArticleId IdType="pubmed">7777057</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Campanari ML, Julie Corbier C, Gaucherot A, Kolb-Cheynel I, Oulad-Abdelghani M, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, Liang C, Chang Q, Zhang W, Yang M, Chen JF. C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol Commun. 2019;7:32. doi: 10.1186/s40478-019-0685-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0685-7</ArticleId><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, Hornburg D, Drepper C, Frank N, Jablonka S, Hansel A, et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat Neurosci. 2016;19:1610&#x2013;1618. doi: 10.1038/nn.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4407</ArticleId><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693&#x2013;708. doi: 10.1093/brain/awr355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr355</ArticleId><ArticleId IdType="pmc">PMC3286329</ArticleId><ArticleId IdType="pubmed">22300873</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derberg O, Gullberg M, Jarvius M, Ridderstr&#xe5;le K, Leuchowius KJ, Jarvius J, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006;3:995&#x2013;1000. doi: 10.1038/nmeth947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth947</ArticleId><ArticleId IdType="pubmed">17072308</ArticleId></ArticleIdList></Reference><Reference><Citation>Song SH, Augustine GJ. Synapsin isoforms and synaptic vesicle trafficking. Mol Cells. 2015;38:936&#x2013;940. doi: 10.14348/molcells.2015.0233.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2015.0233</ArticleId><ArticleId IdType="pmc">PMC4673407</ArticleId><ArticleId IdType="pubmed">26627875</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr A, Sattler R. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD. Brain Res. 2018;1693:98&#x2013;108. doi: 10.1016/j.brainres.2018.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.02.011</ArticleId><ArticleId IdType="pmc">PMC5997509</ArticleId><ArticleId IdType="pubmed">29453960</ArticleId></ArticleIdList></Reference><Reference><Citation>Su MY, Fromm SA, Zoncu R, Hurley JH. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD. Nature. 2020;585:251&#x2013;255. doi: 10.1038/s41586-020-2633-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2633-x</ArticleId><ArticleId IdType="pmc">PMC8054479</ArticleId><ArticleId IdType="pubmed">32848248</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei Y, Harada A, Takeda S, Kobayashi K, Terada S, Noda T, et al. Synapsin I deficiency results in the structural change in the presynaptic terminals in the murine nervous system. J Cell Biol. 1995;131:1789&#x2013;1800. doi: 10.1083/jcb.131.6.1789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.131.6.1789</ArticleId><ArticleId IdType="pmc">PMC2120677</ArticleId><ArticleId IdType="pubmed">8557745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Sheng J, Xu L, Zhan X, Liu J, Jiang H, et al. Cryo-EM structure of C9ORF72-SMCR8-WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc Natl Acad Sci USA. 2020;117:9876&#x2013;9883. doi: 10.1073/pnas.2002110117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002110117</ArticleId><ArticleId IdType="pmc">PMC7211967</ArticleId><ArticleId IdType="pubmed">32303654</ArticleId></ArticleIdList></Reference><Reference><Citation>Troakes C, Maekawa S, Wijesekera L, Rogelj B, Sikl&#xf3;s L, Bell C, et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology. 2012;32:505&#x2013;514. doi: 10.1111/j.1440-1789.2011.01286.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01286.x</ArticleId><ArticleId IdType="pubmed">22181065</ArticleId></ArticleIdList></Reference><Reference><Citation>Trolese MC, Scarpa C, Melfi V, Fabbrizio P, Sironi F, Rossi M, et al. Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice. Mol Ther. 2022 doi: 10.1016/j.ymthe.2022.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.04.018</ArticleId><ArticleId IdType="pmc">PMC9372324</ArticleId><ArticleId IdType="pubmed">35477657</ArticleId></ArticleIdList></Reference><Reference><Citation>Vautrin J. SV2 frustrating exocytosis at the semi-diffusor synapse. Synapse. 2009;63:319&#x2013;338. doi: 10.1002/syn.20610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20610</ArticleId><ArticleId IdType="pubmed">19140166</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540&#x2013;1550. doi: 10.1093/brain/awn071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Liu H, Itoh K, Oh S, Zhao L, Murata D, et al. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021;33:531&#x2013;546.e9. doi: 10.1016/j.cmet.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8579819</ArticleId><ArticleId IdType="pubmed">33545050</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Grierson AJ, De Vos KJ. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases. 2018;9:399&#x2013;408. doi: 10.1080/21541248.2016.1240495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1240495</ArticleId><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Walhout R, Straathof M, Schmidt R, Hendrikse J, Veldink JH, et al. Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. J Neurol Neurosurg Psychiatry. 2016;87:1354&#x2013;1360. doi: 10.1136/jnnp-2016-313959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313959</ArticleId><ArticleId IdType="pmc">PMC5136726</ArticleId><ArticleId IdType="pubmed">27756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Fifita JA, Vucic S, Durnall JC, Kiernan MC, Blair IP, et al. Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry. 2013;84:931&#x2013;935. doi: 10.1136/jnnp-2012-304529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304529</ArticleId><ArticleId IdType="pubmed">23463871</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, McKeever PM, Lau A, Robertson J. Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol Commun. 2019;7:161. doi: 10.1186/s40478-019-0812-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0812-5</ArticleId><ArticleId IdType="pmc">PMC6813971</ArticleId><ArticleId IdType="pubmed">31651360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Iyer LM, He F, Aravind L. Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front Genet. 2012;3:283. doi: 10.3389/fgene.2012.00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00283</ArticleId><ArticleId IdType="pmc">PMC3521125</ArticleId><ArticleId IdType="pubmed">23248642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Augustine GJ. Synapsins and the synaptic vesicle reserve pool: floats or anchors. Cells. 2021;10:658. doi: 10.3390/cells10030658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030658</ArticleId><ArticleId IdType="pmc">PMC8002314</ArticleId><ArticleId IdType="pubmed">33809712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>